| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/12/2006 | US20060229306 4-(4-Ethylpiperazin-1-yl)-5-methyl-2-phenylthieno[2,3-d]pyrimidine-6-carbonitrile; asthma, atopic dermatitis, chronic obstructive pulmonary disease, Crohn's disease, type I and type II diabetes, lymphoid leukemia and other forms of cancer, multiple sclerosis and autoimmune diseases |
| 10/12/2006 | US20060229305 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 10/12/2006 | US20060229304 (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity |
| 10/12/2006 | US20060229303 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 1,4-benzoxazino(2,3,4-ij)quinolin-4-one for example |
| 10/12/2006 | US20060229302 Tricyclic indole derivatives and their use in the treatment of alzheimer's disease |
| 10/12/2006 | US20060229301 To treat inflammatory diseases, immune diseases like autoimmune diseases or allergic diseases, or HIV infection; chemokine receptor antagonists; safe and low-toxic; 1-butyl-3-isobutyl-1,3,8-triazaspiro[4.5]decane-2,4-dione |
| 10/12/2006 | US20060229300 Method for the preparation of enantiomerically pure mirtazapine |
| 10/12/2006 | US20060229299 5ht2c Receptor antagonists in the treatment of schizophrenia |
| 10/12/2006 | US20060229298 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 10/12/2006 | US20060229297 (THIO) Carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists |
| 10/12/2006 | US20060229296 1-[4-(2-Azepan-1-yl-ethoxy)-benzyl-2-(4-hydroxy-phenyl])-3-methyl-1H-indol-5-ol, or salts for treating bone loss |
| 10/12/2006 | US20060229295 Amide derivatives |
| 10/12/2006 | US20060229294 Benzisothiazoles useful for treating or preventing HCV infection |
| 10/12/2006 | US20060229293 Compositions for the treatment of hepatitis C and methods for using compositions for the treatment of hepatitis C |
| 10/12/2006 | US20060229292 Method of treating childhood disorders |
| 10/12/2006 | US20060229291 Concentrated, aqueous solutions of p-methoxybenzoic acid for use in cosmetic and dermatologic formulations |
| 10/12/2006 | US20060229290 Staurosporine derivatives for hypereosinophilic syndrome |
| 10/12/2006 | US20060229289 2-(2-Methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide, aka veliparib, for example; poly(ADP-ribose)polymerase inhibitors; antiinflammatory, antitumor agents; Parkinson's disease |
| 10/12/2006 | US20060229288 Adjust concentration of oocytes in cells of mammals ; stimulant of ovaries follicular growth |
| 10/12/2006 | US20060229287 (S)-1-[(R)-7-(3,5-Dichloro-phenyl)-5-methyl-6-oxo-5-(4-pyrimidin-5-yl-benzyl)-6,7-dihydro-5H-imidazo[1,2- alpha ]imidazole-3-sulfonyl]-azetidine-2-carboxylic acid methyl ester; useful for inflammatory conditions by inhibitory effect upon the interaction of Cellular Adhesion Molecules and Leukointegrins |
| 10/12/2006 | US20060229286 Therapy of diabetes |
| 10/12/2006 | US20060229285 Crystal of intermediate for carbapenem |
| 10/12/2006 | US20060229284 Enhanced occlusive effect photodynamic therapy |
| 10/12/2006 | US20060229283 Cholesterol as an antibiotic for streptococcus pneumoniae |
| 10/12/2006 | US20060229282 New analogues for tetracycline-resistant organisms; Bactericides, bacteriostats; bacterial infections specially against Escherichia coli, Staphylococcus aureus, and Enterococcus faecalis; cancer, diabetes; 7-(2-pyridinyl)doxycycline |
| 10/12/2006 | US20060229281 Cycloalkyl-Hydroxyl Compounds and Compositions for Cholesterol Management and Related Uses |
| 10/12/2006 | US20060229280 2-(2,2 -Dimethylpentyl)-4-(7-methoxy-1, 3-benzodioxol-5-yl)-1-(N,N-di(n-butyl)aminocarbonylmethyl)-pyrroldine-3-carboxylic acid; cardiovascular disorders, raynaud's disease, ischemia, hypotensive agent; with other cardiovascular agents |
| 10/12/2006 | US20060229279 Artemisinins with improved stability and bioavailability for therapeutic drug development and application |
| 10/12/2006 | US20060229278 Antioxidant: methoxyphenyl alkyl triphenylphosphonium or methoxy dioxocyclohexadiene alkyl triphenylphosphonium derivatives; Parkinson's, Alzheimer's disease, Huntington's Chorea and Friedreich's Ataxia |
| 10/12/2006 | US20060229277 Stabilized pharmaceutical compositions comprising an HMG-CoA reductase inhibitor |
| 10/12/2006 | US20060229276 Use of glycosoaminoglycans for the prevention and treatment of sepsis |
| 10/12/2006 | US20060229275 Production method of 2-deoxy-L-ribofuranosyl chloride compound |
| 10/12/2006 | US20060229274 Weight reduction and inhibition of hypertriglyceridemia medicine containing ATP as effective ingredient |
| 10/12/2006 | US20060229273 High affinity oligonucleotide ligands to growth factors |
| 10/12/2006 | US20060229269 administering to a subject having cerebral vasospasm an effective amount for treating cerebral vasospasm of a R-type voltage-dependent calcium channel inhibitor SNX-482 ( a polypeptide from spider; toxin from the venom of the tarantula Hysterocrates gigas) |
| 10/12/2006 | US20060229265 Nicotinamide riboside and analogues thereof |
| 10/12/2006 | US20060229264 Crystalline 6-n-pyridylmethylaminoindolocarbazole compounds |
| 10/12/2006 | US20060229262 Pharmaceutical composition for treatment of infection with drug resistant bacterium and disinfectant |
| 10/12/2006 | US20060229261 Acarbose methods and formulations for treating chronic constipation |
| 10/12/2006 | US20060229260 Substituted fused heterocyclic C-glycosides |
| 10/12/2006 | US20060229259 AI-2 compounds and analogs based on Salmonella typhimurium LsrB structure |
| 10/12/2006 | US20060229258 Steroidal compositions containing hydroxycarboxylic acids and methods of using the same |
| 10/12/2006 | US20060229257 For inhibiting thrombin in the prophylaxis or therapy of disease |
| 10/12/2006 | US20060229256 Enternal administration of arginine and glutamine for abnormal vascular proliferation |
| 10/12/2006 | US20060229255 Identification of n-alkylglycine trimers for induction of apoptosis |
| 10/12/2006 | US20060229254 Compounds having prolyl oligopeptidase inhibitory activity |
| 10/12/2006 | US20060229253 Pentapeptide compounds and uses related thereto |
| 10/12/2006 | US20060229251 Disrupting sex steroid signal to thymus; bone marrow or hematopoitic cells |
| 10/12/2006 | US20060229242 Composition comprising a pulmonary surfactant and a pde2 inhibitor |
| 10/12/2006 | US20060229239 Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis |
| 10/12/2006 | US20060229237 Treatment of gastrointestinal distress |
| 10/12/2006 | US20060229233 Compositions and methods for treating neurological disorders |
| 10/12/2006 | US20060228784 Asparagine-linked oligosaccharide derivative containing a fucose in N-acetylglucosamine on the nonreducing terminal side; the asparagine has amino group protected with a lipophilic group |
| 10/12/2006 | US20060228778 Novel vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 10/12/2006 | US20060228752 Genetic polymorphisms in the preprotachykinin gene |
| 10/12/2006 | US20060228745 Gene detection assay for improving the likelhood of an effective response to an ErbB antagonist cancer therapy |
| 10/12/2006 | US20060228715 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof |
| 10/12/2006 | US20060228700 Novel retrovirus associated with myelodysplastic syndromes and uses thereof |
| 10/12/2006 | US20060228433 Method for restoration of gap junctional intercellular connection |
| 10/12/2006 | US20060228432 alpha-glucosidase inhibitors from a natural source |
| 10/12/2006 | US20060228431 Nutriceutical tea |
| 10/12/2006 | US20060228429 Pharmaceutical composition and method for the treatment and prevention of prostatic hyperplasia and prostatitis using roystonea regia (royal palm) fruits |
| 10/12/2006 | US20060228428 extract of at least one plant selected from Coptis chinensis Franch., Phellodendron genus plant, Sanguinaria canadensis and Chelidonium majus var. asiaticum; plant powdery mildew, anthracnose of pepper, damping-off of cucumber and gray mold rot of strawberry |
| 10/12/2006 | US20060228425 Compositions and methods for destabilizing lysosomes to increase oncogenic or aberrant protein degradation |
| 10/12/2006 | US20060228424 a mixture of a cationic phosphate binder and magnesium lipoate, used for inhibiting the absorption of phosphorus from the gastrointestinal systems of mammals; prevention of hyperphosphatemia |
| 10/12/2006 | US20060228420 Pharmaceutical compositions comprising microparticles for delivery into neurons |
| 10/12/2006 | US20060228419 Solvent-free process for preparation of hydrophilic dispersions of nanoparticles of inclusion complexes |
| 10/12/2006 | US20060228418 Topical ointment and method for making and using same |
| 10/12/2006 | US20060228414 Method for the preparation of controlled release formulations |
| 10/12/2006 | US20060228412 (-)-Hydroxycitric acid for delaying gastric emptying |
| 10/12/2006 | US20060228411 Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs |
| 10/12/2006 | US20060228410 Flavored taste-masked pharmaceutical formulation made using a one-step coating process |
| 10/12/2006 | US20060228407 Enhanced delivery via serpin enzyme complex receptor |
| 10/12/2006 | US20060228405 ansamycins such as 17-allylaminogeldanamycin (17-AAG) and the overall formulation is free of medium and long chain triglycerides; can be freeze dried, sterilized; provide for higher concentrations of lipophilic compound per aqueous physiological unit volume |
| 10/12/2006 | US20060228404 Compositions and methods for treatment of hypertrophic tissues |
| 10/12/2006 | US20060228403 Nutritional supplements for cardiovascular health |
| 10/12/2006 | US20060228397 Dietary supplement, and methods of use |
| 10/12/2006 | US20060228396 Arginine-containing compositions and methods for increasing blood flow using same |
| 10/12/2006 | US20060228394 Ocular solutions |
| 10/12/2006 | US20060228393 Ocular solutions |
| 10/12/2006 | US20060228384 Control of biofilm with a biofilm inhibitor |
| 10/12/2006 | US20060228383 comprising a fluoroether anesthetic compound selected from sevoflurane, desflurane, isoflurane, enflurane and methoxyflurane, and at least one stabilizer agent selected from propylene glycol, polyethylene glycol, hexylene glycol, 1,3-butylene glycol and a saturated cyclic alcohol preferably menthol |
| 10/12/2006 | US20060228333 Methods for control of tumors and chronic infections by modulating immunologically informed carriers homing to tolerogenic organs or tissues |
| 10/12/2006 | US20060228325 that bind target proteins, such as monoclonal antibodies, for in vitro bioassays, or for in vivo diagnosis or therapy |
| 10/12/2006 | US20060228321 sebum regulator, keratolytic agent, anti-inflammatory agent, bacterial lipase inhibitor and bacterial proliferation inhibitor |
| 10/12/2006 | US20060228320 Agent for therapy or treatment of wound |
| 10/12/2006 | US20060228308 Oral health care drink and method for reducing malodors |
| 10/12/2006 | US20060228306 Combination antihistamine and steroid medication |
| 10/12/2006 | US20060228305 Pharmaceutical compositions based on anticholinergics and inhibitors of tnf alpha synthesis or action |
| 10/12/2006 | US20060228301 Methods and compositions for determining targeted drug sensitivity and resistance in a cancer subject |
| 10/12/2006 | US20060225195 Antibacterial and antifungal material |
| 10/12/2006 | DE20321314U1 Retarded release pharmaceutical composition, obtained without use of organic solvents or water by densifying mixture of active agent and retarding polymer in heated rollers |
| 10/12/2006 | DE19940944B4 Retardierte, orale, pharmazeutische Darreichungsformen Prolonged-release oral pharmaceutical dosage forms |
| 10/12/2006 | DE102006007831A1 Vernetztes Kohlehydratpolymer, insbesondere auf Basis von Polysacchariden und/oder Oligosacchariden und/oder Polyolen Cross-linked carbohydrate polymer, in particular based on polysaccharides and / or oligosaccharides and / or polyols |
| 10/12/2006 | DE102005016547A1 Substituierte 5,6,7,8-Tetrahydro-imidazo(1,2-a)pyridin-2-ylamin-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln Substituted 5,6,7,8-tetrahydro-imidazo (1,2-a) pyridin-2-ylamine compounds and their use for preparing medicaments |
| 10/12/2006 | DE102005016345A1 Neue Verwendung von 2-Phenyl-substituierten Imidazotriazinon-Derivaten New use of 2-phenyl-substituted imidazotriazinone derivatives |
| 10/12/2006 | DE102005016170A1 4,5,6,7- Tetrahydro-isoxazolo(4,5c)pyridin-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln 4,5,6,7-tetrahydro-isoxazolo (4,5c) pyridine compounds and their use for the preparation of medicaments |
| 10/12/2006 | DE102005015632A1 Verwendung von Polyisobuten enthaltenden Copolymerisaten in Lichtschutzmitteln Use of polyisobutene-containing copolymers in light stabilizers |
| 10/12/2006 | DE102005015254A1 New indazole derivatives are serum and glucocorticoid regulated kinase inhibitors useful to treat and/or prevent e.g. diabetes, cardiovascular diseases, fibrosis and inflammatory diseases |
| 10/12/2006 | DE10064219B4 Neue Fentanyl und/oder dessen Derivate enthaltende enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung New fentanyl and / or derivatives thereof containing containing pharmaceutical composition for nasal administration |